• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种源自主要草花粉过敏原Phl p 1的B细胞表位肽可增强过敏原特异性二次抗体反应,且无需过敏原特异性T细胞辅助。

A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help.

作者信息

Narayanan Meena, Freidl Raphaela, Focke-Tejkl Margarete, Baranyi Ulrike, Wekerle Thomas, Valenta Rudolf, Linhart Birgit

机构信息

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, 1090 Vienna, Austria; and.

Section of Transplantation Immunology, Department of Surgery, Medical University of Vienna, 1090 Vienna, Austria.

出版信息

J Immunol. 2017 Feb 15;198(4):1685-1695. doi: 10.4049/jimmunol.1501741. Epub 2017 Jan 16.

DOI:10.4049/jimmunol.1501741
PMID:28093528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5292585/
Abstract

More than 40% of allergic patients suffer from grass pollen allergy. Phl p 1, the major timothy grass pollen allergen, belongs to the cross-reactive group 1 grass pollen allergens that are thought to initiate allergic sensitization to grass pollen. Repeated allergen encounter boosts allergen-specific IgE production and enhances clinical sensitivity in patients. To investigate immunological mechanisms underlying the boosting of allergen-specific secondary IgE Ab responses and the allergen epitopes involved, a murine model for Phl p 1 was established. A B cell epitope-derived peptide of Phl p 1 devoid of allergen-specific T cell epitopes, as recognized by BALB/c mice, was fused to an allergen-unrelated carrier in the form of a recombinant fusion protein and used for sensitization. This fusion protein allowed the induction of allergen-specific IgE Ab responses without allergen-specific T cell help. Allergen-specific Ab responses were subsequently boosted with molecules containing the B cell epitope-derived peptide without carrier or linked to other allergen-unrelated carriers. Oligomeric peptide bound to a carrier different from that which had been used for sensitization boosted allergen-specific secondary IgE responses without a detectable allergen-specific T cell response. Our results indicate that allergen-specific secondary IgE Ab responses can be boosted by repetitive B cell epitopes without allergen-specific T cell help by cross-linking of the B cell epitope receptor. This finding has important implications for the design of new allergy vaccines.

摘要

超过40%的过敏患者患有草花粉过敏症。Phl p 1是梯牧草花粉的主要过敏原,属于交叉反应性第1组草花粉过敏原,被认为会引发对草花粉的过敏致敏。反复接触过敏原会增加过敏原特异性IgE的产生,并增强患者的临床敏感性。为了研究过敏原特异性二级IgE抗体反应增强的免疫机制以及所涉及的过敏原表位,建立了一个针对Phl p 1的小鼠模型。将一种缺乏过敏原特异性T细胞表位的Phl p 1的B细胞表位衍生肽(如BALB/c小鼠所识别的)以重组融合蛋白的形式与一种与过敏原无关的载体融合,并用于致敏。这种融合蛋白能够在没有过敏原特异性T细胞辅助的情况下诱导产生过敏原特异性IgE抗体反应。随后,用含有B细胞表位衍生肽但无载体或与其他与过敏原无关的载体相连的分子来增强过敏原特异性抗体反应。与用于致敏的载体不同的载体结合的寡聚肽增强了过敏原特异性二级IgE反应,且未检测到过敏原特异性T细胞反应。我们的结果表明,通过B细胞表位受体的交联,重复性B细胞表位可在没有过敏原特异性T细胞辅助的情况下增强过敏原特异性二级IgE抗体反应。这一发现对新型过敏疫苗的设计具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/4a63d3329ebb/JI_1501741_f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/577693d15f47/JI_1501741_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/f73dbd47a604/JI_1501741_f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/5087685299c7/JI_1501741_f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/fd5f212ea8ec/JI_1501741_f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/7da70f22d1d7/JI_1501741_f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/e2c5d1cf4a9f/JI_1501741_f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/7b3d7def7931/JI_1501741_f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/5eb209ee40ff/JI_1501741_f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/4a63d3329ebb/JI_1501741_f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/577693d15f47/JI_1501741_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/f73dbd47a604/JI_1501741_f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/5087685299c7/JI_1501741_f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/fd5f212ea8ec/JI_1501741_f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/7da70f22d1d7/JI_1501741_f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/e2c5d1cf4a9f/JI_1501741_f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/7b3d7def7931/JI_1501741_f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/5eb209ee40ff/JI_1501741_f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a07/5292585/4a63d3329ebb/JI_1501741_f9.jpg

相似文献

1
A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help.一种源自主要草花粉过敏原Phl p 1的B细胞表位肽可增强过敏原特异性二次抗体反应,且无需过敏原特异性T细胞辅助。
J Immunol. 2017 Feb 15;198(4):1685-1695. doi: 10.4049/jimmunol.1501741. Epub 2017 Jan 16.
2
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.一种基于B细胞表位的草花粉过敏免疫治疗疫苗的作用机制、安全性和有效性
EBioMedicine. 2016 Sep;11:43-57. doi: 10.1016/j.ebiom.2016.08.022. Epub 2016 Aug 20.
3
Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.主要梯牧草花粉过敏原Phl p 1上IgE表位的空间聚集:对变应原活性的重要性
J Allergy Clin Immunol. 2006 Jun;117(6):1336-43. doi: 10.1016/j.jaci.2006.02.012. Epub 2006 Apr 27.
4
Discontinuous IgE-binding epitopes contain multiple continuous epitope regions: results of an epitope mapping on recombinant Hol l 5, a major allergen from velvet grass pollen.不连续的IgE结合表位包含多个连续表位区域:对重组绒毛草花粉主要变应原Hol l 5进行表位作图的结果
Clin Exp Allergy. 2001 Feb;31(2):331-41. doi: 10.1046/j.1365-2222.2001.01049.x.
5
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.源自主要草花粉过敏原Phl p 1的B细胞表位的非过敏性合成肽,用于过敏疫苗接种。
FASEB J. 2001 Sep;15(11):2042-4. doi: 10.1096/fj.01-0016fje. Epub 2001 Jul 24.
6
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain.一种人源单克隆IgE抗体鉴定出主要梯牧草花粉过敏原Phl p 5的一个高致敏性片段:含表位结构域的分子、免疫和结构特征
J Immunol. 2000 Oct 1;165(7):3849-59. doi: 10.4049/jimmunol.165.7.3849.
7
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.一种用于草花粉过敏的重组、低变应原性、基于肽的疫苗的研发与特性分析。
J Allergy Clin Immunol. 2015 May;135(5):1207-7.e1-11. doi: 10.1016/j.jaci.2014.09.012. Epub 2014 Nov 13.
8
Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.对新的B细胞表位产生抗体反应表明了变应原免疫疗法的疫苗接种特性。
Eur J Immunol. 1999 Jun;29(6):2026-36. doi: 10.1002/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2.
9
Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid.应用重组草花粉杂交进行皮肤试验检测儿童对真草花粉的致敏性。
Pediatr Allergy Immunol. 2019 Feb;30(1):59-65. doi: 10.1111/pai.12991. Epub 2018 Nov 25.
10
Mapping of T-cell epitopes of Phl p 5: evidence for crossreacting and non-crossreacting T-cell epitopes within Phl p 5 isoallergens.Phl p 5的T细胞表位图谱:Phl p 5同种变应原内交叉反应和非交叉反应T细胞表位的证据
Clin Exp Allergy. 1998 Dec;28(12):1538-48. doi: 10.1046/j.1365-2222.1998.00432.x.

引用本文的文献

1
Adoptive Cell Therapy in Mice Sensitized to a Grass Pollen Allergen.对草花粉过敏原致敏的小鼠的过继性细胞疗法。
Antibodies (Basel). 2024 Jun 18;13(2):48. doi: 10.3390/antib13020048.
2
Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand.基于脂质的重组纳米颗粒疫苗的免疫原性:危险信号与助力之手
Pharmaceutics. 2023 Dec 23;16(1):24. doi: 10.3390/pharmaceutics16010024.
3
Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?过敏性鼻炎:我们对变应原特异性免疫疗法了解多少?

本文引用的文献

1
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.一种基于B细胞表位的草花粉过敏免疫治疗疫苗的作用机制、安全性和有效性
EBioMedicine. 2016 Sep;11:43-57. doi: 10.1016/j.ebiom.2016.08.022. Epub 2016 Aug 20.
2
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.基于前S区的草花粉过敏疫苗BM32免疫疗法可诱导抗体反应,预防乙型肝炎感染。
EBioMedicine. 2016 Sep;11:58-67. doi: 10.1016/j.ebiom.2016.07.023. Epub 2016 Aug 8.
3
Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.
Front Allergy. 2021 Oct 28;2:747323. doi: 10.3389/falgy.2021.747323. eCollection 2021.
4
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.预防性给予非变应原性贝母 1 肽可减少主要桦树花粉变应原贝母 1 的过敏致敏。
Front Immunol. 2021 Oct 26;12:744544. doi: 10.3389/fimmu.2021.744544. eCollection 2021.
5
Identification of immunodominant IgE binding epitopes of Der p 24, a major allergen of .鉴定屋尘螨主要变应原Der p 24的免疫显性IgE结合表位
Clin Transl Allergy. 2019 May 23;9:28. doi: 10.1186/s13601-019-0266-7. eCollection 2019.
6
Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.过敏原特异性抗体调节次级过敏原特异性免疫应答。
Front Immunol. 2019 Jan 17;9:3131. doi: 10.3389/fimmu.2018.03131. eCollection 2018.
7
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.鼻内给予变应原可增加特异性 IgE,而鼻内奥马珠单抗则不会增加血清 IgE 水平——一项初步研究。
Allergy. 2018 May;73(5):1003-1012. doi: 10.1111/all.13343. Epub 2017 Dec 12.
一种过敏免疫疗法的发展催生了新型乙肝疫苗。
EBioMedicine. 2016 Sep;11:5-6. doi: 10.1016/j.ebiom.2016.07.032. Epub 2016 Jul 27.
4
IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment.长期接受全身性环孢素A治疗的特应性皮炎患者对外源性和内源性过敏原的IgE反应
Allergy. 2016 Jan;71(1):115-8. doi: 10.1111/all.12711. Epub 2015 Sep 17.
5
Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber.在环境挑战舱中因接触草花粉而使特应性皮炎恶化。
J Allergy Clin Immunol. 2015 Jul;136(1):96-103.e9. doi: 10.1016/j.jaci.2015.04.015. Epub 2015 Jun 1.
6
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.一种用于草花粉过敏的重组、低变应原性、基于肽的疫苗的研发与特性分析。
J Allergy Clin Immunol. 2015 May;135(5):1207-7.e1-11. doi: 10.1016/j.jaci.2014.09.012. Epub 2014 Nov 13.
7
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.针对 M1 原表位的抗体靶向膜表达的 IgE B 细胞受体可减少 IgE 的产生。
Sci Transl Med. 2014 Jul 2;6(243):243ra85. doi: 10.1126/scitranslmed.3008961.
8
The high molecular weight glutenin subunit Bx7 allergen from wheat contains repetitive IgE epitopes.小麦高分子量谷蛋白亚基 Bx7 过敏原含有重复的 IgE 表位。
Allergy. 2014 Oct;69(10):1316-23. doi: 10.1111/all.12464. Epub 2014 Aug 2.
9
Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS.尽管艾滋病患者CD4+ T细胞减少,但IgE相关过敏及过敏原特异性IgE仍持续存在。
PLoS One. 2014 Jun 4;9(6):e97893. doi: 10.1371/journal.pone.0097893. eCollection 2014.
10
The production and regulation of IgE by the immune system.免疫系统产生和调节 IgE。
Nat Rev Immunol. 2014 Apr;14(4):247-59. doi: 10.1038/nri3632. Epub 2014 Mar 14.